Health Care • Medical/Nursing Services
$22.00 ▲ +0.16
(+0.71%)
MKT CAP: $2.81B • VOL: 869.0K
52W L $19 52W H $29
ROARABLE / RQD
D+ • 57/100
PIOTROSKI
6 / 9
PRVA // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $0 | $0 | $0 |
| YoY Revenue Growth % | — | — | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $34.2M | $17.0M | $20.6M |
| Operating Margin % | — | — | — |
| Net Income (GAAP) | $22.9M | $14.4M | $23.1M |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $163.4M | $109.3M | $80.8M |
| Capital Expenditures (CapEx) | — | — | — |
| Free Cash Flow (FCF) | $163.4M | $109.3M | $80.8M |
| FCF Margin % | — | — | — |
| Return on Invested Capital (ROIC %) | 10.5% | 9.3% | — |
| Cash & Short-Term Equivalents | $479.7M | $491.1M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $737.2M | $635.2M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR PRVA.